Is it Influenza – or something else?
Dr. Benoît Visseaux and Dr. Celestin Alexis Agbessi discuss their experiences with syndromic multiplex diagnostics at Bichat-Claude Bernard hospital in Paris – is one of the first users of QIAstat-Dx in Europe.
The Bichat-Claude Bernard Hospital
is a marriage of a squat, red and yellow stone building to an imposing 1970’s high-rise of sleek steel and windows. It sits just inside the beltway that separates Paris from its suburbs, and is one of the most important emergency hospitals in the entire city. More than 90,000 urgent-care patients are treated here per year, and the hospital offers further specializations in different medical and surgical disciplines.
Bringing the lab to the emergency room
Célestin Alexis Agbessi
is an emergency physician at Bichat-Claude Bernard hospital and reviewer for the World Health Organization. He speaks five languages, has experience with politics and public health, and is passionate in finding improvements in the medical treatment of patients.
A class of its own:
With novel Sample to Insight solutions powered by QIAGEN chemistries, the QIAstat-Dx enables fast, cost-effective and flexible syndromic testing.
– Results in about one hour
– One-step diagnostics by an all-in-one mini-lab
– Contains wet and dry reagents
– Comprehensive controls from start to finish
– Room temperature storage
– Exclusive dry swap protocol
The broader pipeline of assays and applications for QIAstat-Dx spans infectious diseases, oncology and companion diagnostics, transplantation patients, quantitative analysis, and immunoassay testing. The additional capability to process immunoassays creates unmatched target and application versatility, as well as disease management options.